The April 2025 issue of FASEB BioAdvances delves into the effects of global warming on obesity, innovative treatments for hypertension and kidney injury, gene recombination in neural tissues, and the future of precision medicine through AI and biomedical informatics.
Researchers found that probiotic bacteria Limosilactobacillus reuteri can regulate gut hormones, revealing new insights into their potential health benefits. The study, published in The FASEB Journal, suggests probiotics may have systemic effects beyond digestion, impacting immune function and hormone secretion.
FASEB welcomes the inaugural Fellows for the Future cohort, supporting early-career researchers from historically excluded groups who are dedicated to promoting inclusion in scientific societies.
Experiencing discrimination correlates with differences in gene expression by race and sex, affecting immune response and disease risk, according to a study in The FASEB Journal. Researchers found 28 genes linked to inflammation and tumorigenesis were differentially expressed in those perceiving high discrimination.
FASEB has released recommendations for integrating generative AI into biological and biomedical research, providing guidance on innovation, scientific integrity, data security, and workforce development.
New research in the FASEB Journal reveals a signal that the body adds to an mRNA can disrupt placental development and lead to fetal growth restriction.
The Federation of American Societies for Experimental Biology (FASEB) selects the first cohort for its 2024 MOSAIC program, which helps postdoctoral and new investigators transition into independent faculty careers at research-intensive institutions.
FASEB Journals announce the launch of a new article type, Research Letters, designed to offer scientists a fast, focused platform for sharing significant research findings.
Latest research in the FASEB Journal reveals an antibody called bFKB1 improves liver disease and atherosclerosis in a mouse model of metabolic dysfunction-associated steatohepatitis (MASH), which is associated with obesity.
New research in FASEB BioAdvances reveals that a fluorescent dye could help scientists listen to biochemical conversations between cartilage and bone during the earliest stages of osteoarthritis—even before the disease causes pain.
The Federation of American Societies for Experimental Biology (FASEB) announces the 2024 recipients of its CARES Award, which supports researchers in their caregiving role and enables them to focus on their professional development and career advancement.
The Federation of American Societies for Experimental Biology (FASEB) selected nine scientists as the 2024 Howard Garrison Advocacy Fellows.
The Federation of American Societies for Experimental Biology (FASEB) is seeking nominations for its 2025 Excellence in Science Awards, recognizing outstanding women scientists dedicated to advancing the professional development of others, contributing to their scientific society, and impacting the scientific community.
The Federation of American Societies for Experimental Biology (FASEB) and the National Institutes of Health (NIH) invite researchers to submit proposals to the FASEB DataWorks! Prize in recognition for their groundbreaking secondary analysis and data reuse projects that contribute to advancing human health.
In addition to the Journal of Pharmacology and Experimental Therapeutics (JPET), the American Society for Pharmacology and Experimental Therapeutics (ASPET) is including two of its other highly respected journals as part of its Editorial Fellowship program.
The Federation of American Societies for Experimental Biology (FASEB), the largest coalition of biomedical research associations in the United States, received a $2.3 million grant over five years to enhance diversity within the academic biomedical research workforce.
The Federation of American Societies for Experimental Biology (FASEB) invites researchers to submit their most captivating research visuals to the FASEB BioArt Awards competition.
The Federation of American Societies for Experimental Biology (FASEB) appoints the 2024–2025 Early-Career Representatives to the FASEB Board and Science Policy Committee (SPC). As voting members of the FASEB Board and SPC, these newly named ECRs will share unique insights of early-career scientists.
Innovative B cell therapy shows promise in delaying disease onset and reducing inflammation in ALS models, paving the way for Phase I clinical trials.
The Federation of American Societies for Experimental Biology's innovative reverse mentoring program transforms mentorship by empowering early-career researchers to lead the way.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right